In another study on 87 MDS patients, mutations in TP53 (HR, 2.30; P = .027), TET2 (HR, 2.40; P = .033), or DNMT3A (HR, 2.08; P = .049) were reported to be associated with shorter OS after alloBMT (17). The gene discussed is TET2; the disease is myelodysplastic syndrome.